Ryan T. Bishop

Dual Blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) Pathways Synergistically Inhibits Rhabdomyosarcoma Cell Growth <i>In Vitro</i> and <i>In Vivo</i>

Jane Renshaw, Kathryn R. Taylor, Ryan T. Bishop et al. · Clinical Cancer Research · 2013 · 153 citations · Full text

Medicine, Oncology, Pharmacology +17

Antitumor Activity of Sustained N-Myc Reduction in Rhabdomyosarcomas and Transcriptional Block by Antigene Therapy

Roberto Tonelli, Alan McIntyre, Consuelo Camerin et al. · Clinical Cancer Research · 2011 · 90 citations

Medicine, Cancer Biology, Oncology +17

γδ-Enriched CAR-T cell therapy for bone metastatic castrate-resistant prostate cancer

Jeremy S. Frieling, Leticia Tordesillas, Xiomar Bustos et al. · Science Advances · 2023 · 66 citations · Full text

Medicine, Oncology, Pharmacology +17

Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice

Silvia Marino, Daniëlle de Ridder, Ryan T. Bishop et al. · EBioMedicine · 2019 · 44 citations · Full text

Medicine, Oncology, Pharmacology +15

TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis

Prabha Peramuhendige, Silvia Marino, Ryan T. Bishop et al. · Scientific Reports · 2018 · 39 citations · Full text

Medicine, Cancer Biology, Oncology +17